中文

Payer

Medicare spent hundreds of millions of dollars on ineligible drugs, audit finds

An HHS OIG audit shows that Medicare Part D paid $587.7 million between 2021 and 2023 for five drugs that had been switched to over-the-counter status, primarily involving generic versions of Voltaren. CMS's reliance on outdated FDA data and failure to promptly notify plans led to increasing non-compliant payments each year. The OIG recommended that CMS issue timeframes similar to the FDA's, and CMS has agreed.

Payer
UnitedHealthcare cuts prior authorization from 1,700 codes

UnitedHealth Insurance announced that starting in October, it will eliminate prior authorization requirements for approximately 1,700 medical codes, covering commercial, Medicare Advantage, Medicaid, and ACA plans, accounting for about 30% of its total prior authorizations. This move aims to respond to public dissatisfaction with administrative barriers and to address regulatory pressure.

Payer
Medicaid losses leave more patients paying cash, Epic finds

A new Epic Research analysis finds that as Medicaid enrollment has significantly declined after the pandemic, the proportion of patients paying out of pocket in U.S. emergency departments and other healthcare settings has risen notably. In the second quarter of 2026, the self-pay rate in emergency departments reached 7.6%, up 2.1 percentage points from 5.5% in early 2022, while Medicaid coverage fell from 18.2% to 16.1%. The study is based on over 550 million visits and notes that the budget reconciliation bill passed by Republicans last year will further cut nearly $1 trillion in Medicaid funding, with an estimated nearly 6 million people expected to lose this insurance over the next decade.

Payer
Employee healthcare costs expected to rise nearly 10% in 2027, employers face dual pressure of benefits and finances

According to the latest Aon research, the average healthcare cost per employee for U.S. employers in 2027 is expected to exceed $19,000, up 9.5% year-over-year, marking the fourth consecutive year of near-double-digit increases. Employee out-of-pocket costs have also risen significantly, reaching an average of $5,297 per person in 2026. The cost surge is driven by the high prevalence of chronic diseases, the adoption of specialty drugs and GLP-1 therapies, and AI-assisted clinical coding inflating bills. Employers face a dilemma between benefit budgets and salary growth.

Payer
Elevance Behavioral Health Welcomes New President

Carelon Behavioral Health, a division of Elevance, announced that Dr. Patrick Fox has assumed the role of president effective immediately, succeeding Corbin Petro. Fox brings thirty years of clinical psychiatry and behavioral health leadership experience and previously served as president of Wellpoint New Jersey. Concurrently, Patrick Gillespie has taken over as president of Wellpoint New Jersey.

Payer
Humana Appoints Physician Executive Dr. Shantanu Nundy as Chief Medical Officer

Humana announced Thursday that Dr. Shantanu Nundy will become its chief medical officer, effective Aug. 31. Nundy, who previously served as executive vice president of care delivery and chief health officer at Accolade, will bring a clinical perspective to product design, platform development, and AI use. He replaces Kate Goodrich, who left in October 2025 for a role at UnitedHealth. The appointment comes as Humana focuses on margin improvement and operational efficiency.

Payer
Federal judge vacates Trump admin restrictions on ACA gender-affirming care

U.S. District Judge Nathaniel Gorton ruled that HHS unlawfully revised essential health benefit scope without a required CMS actuary certification. The decision, hailed by California AG Rob Bonta, reinstates ACA cost-sharing protections for gender-affirming care but leaves administrative details unresolved.

Payer

Our partners